Modification of the ALSFRS-R for Utilization in Individuals Not Using Noninvasive Ventilation

References

1. 1.↵
   1. Perrin C,
   2. Unterborn JN,
   3. Ambrosio CD,
   4. Hill NS

   . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29(1):5-27.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Baxter SK,
   2. Johnson M,
   3. Clowes M,
   4. O'Brien D,
   5. Norman P,
   6. Stavroulakis T,
   7. et al

   . Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener 2019;20(7-8):461-472.

   OpenUrl
3. 3.↵
   1. Cedarbaum JM,
   2. Stambler N,
   3. Malta E,
   4. Fuller C,
   5. Hilt D,
   6. Thurmond B,
   7. et al

   . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169(1-2):13-21.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996;53(2):141-147.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Kaufmann P,
   2. Levy G,
   3. Montes J,
   4. Buchsbaum R,
   5. Barsdorf AI,
   6. Battista V,
   7. et al

   ; QALS study group. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multi-center clinical trial. Amyotroph Lateral Scler 2007;8(1):42-46.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.
   1. Kaufmann P,
   2. Levy G,
   3. Thompson JLP,
   4. DelBene ML,
   5. Battista V,
   6. Gordon PH,
   7. et al

   . The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64(1):38-43.

   OpenUrlCrossRef
7. 7.↵
   1. Maier A,
   2. Holm T,
   3. Wicks P,
   4. Steinfurth L,
   5. Linke P,
   6. Munch C,
   7. et al

   . Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler 2012;13(2):210-216.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Pinto S,
   2. de Carvalho M

   . The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener 2015;16(1-2):120-123.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Ragette R,
   2. Mellies U,
   3. Schwake C,
   4. Voit T,
   5. Teschler H

   . Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002;57(8):724-728.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Simonds AK

    . Chronic hypoventilation and its management. Eur Respir Rev 2013;22(129):325-332.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Brooks BR,
    2. Miller RG,
    3. Swash M,
    4. Munsat TL

    ; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293-299.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Harris PA,
    2. Taylor R,
    3. Minor BL,
    4. Elliott V,
    5. Fernandez M,
    6. O'Neal L,
    7. et al

    ; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019;95:103208.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Harris PA,
    2. Taylor R,
    3. Thielke R,
    4. Payne J,
    5. Gonzalez N,
    6. Conde JG

    . Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-381.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Quanjer PH,
    2. Tammeling GJ,
    3. Cotes JE,
    4. Pedersen OF,
    5. Peslin R,
    6. Yernault JC

    . Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.

    OpenUrlPubMedWeb of Science
15. 15.↵
    1. Andersen PM,
    2. Borasio GD,
    3. Dengler R,
    4. Hardiman O,
    5. Kollewe K,
    6. Leigh PN,
    7. et al

    . EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12(12):921-938.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.
    1. Bourke SC,
    2. Shaw PJ,
    3. Gibson GJ

    . Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS. Neurology 2001;57(11):2040-2044.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Phukan J,
    2. Hardiman O

    . The management of amyotrophic lateral sclerosis. J Neurol 2009;256(2):176-186.

    OpenUrlPubMedWeb of Science
18. 18.↵
    1. Hillel AD,
    2. Miller RM,
    3. Yorkston K,
    4. McDonald E,
    5. Norris FH,
    6. Konikow N

    . Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989;8(3):142-150.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Heiman-Patterson TD,
    2. Cudkowicz ME,
    3. De Carvalho M,
    4. Genge A,
    5. Hardiman O,
    6. Jackson CE,
    7. et al

    . Understanding the use of NIV in ALS: results of an international ALS specialist survey. Amyotroph Lateral Scler Frontotemporal Degener 2018;19(5-6):331-341.

    OpenUrl
20. 20.↵
    1. Jackson C,
    2. De Carvalho M,
    3. Genge A,
    4. Heiman-Patterson T,
    5. Shefner JM,
    6. Wei J,
    7. et al

    . Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Amyotroph Lateral Scler Frontotemporal Degener 2018;19(7-8):506-512.

    OpenUrl